Profound Medical Revenue Growth Rates (PROF), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Profound Medical Corp   (NASDAQ: PROF)
 

PROF's Revenue Growth by Quarter and Year

Profound Medical 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/PROF/growth
https://api.csimarket.com/api/v1/companies/PROF/fundamentals
https://api.csimarket.com/api/v1/companies/PROF/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
PROF Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 9.83
2nd Quarter June 2.48
1st Quarter March 5.34
FY 17.65

PROFs Annual Revenue
Profound Medical 's Revenue in the fiscal year 2025 $ 16.10 millions
Profound Medical 's Revenue in the fiscal year 2024 $ 10.68 millions
Profound Medical 's Revenue in the fiscal year 2023 $ 7.20 millions
Profound Medical 's Revenue in the fiscal year 2022 $ 6.68 millions
Profound Medical 's Revenue in the fiscal year 2021 $ 6.87 millions




PROF Revenue third quarter 2026 Y/Y Growth Comment
Profound Medical Corp achieved in the third quarter 2026, above Company average Revenue rise of 85.82% year on year, to $ 9.83 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 84 other companies have achieved higher Revenue growth. While Profound Medical Corp ' s Revenue jump of 85.82% ranks overall at the positon no. 1505 in the third quarter 2026.


PROF Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 85.82 %
2nd Quarter June 12.22 %
1st Quarter March 103.82 %
FY   -

Financial Statements
Profound Medical 's third quarter 2026 Revenue $ 9.83 millions PROF's Income Statement
Profound Medical 's third quarter 2025 Revenue $ 5.29 millions Quarterly PROF's Income Statement


PROF Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 296.37 %
2nd Quarter June -53.56 %
1st Quarter March -10.7 %
FY (Year on Year)   -


Back to PROF Growth rate Comparisons >> Back to PROF Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #85
Healthcare Sector #256
Overall #1505

Revenue Y/Y Growth Statistics
High Average Low
103.62 % 40.71 % -41.99 %
(Jun 30 2026)   (Sep 30 2025)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #85
Healthcare Sector #256
Overall #1505
Revenue Y/Y Growth Statistics
High Average Low
103.62 % 40.71 % -41.99 %
(Jun 30 2026)   (Sep 30 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Profound Medical 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
139.21 % 8.46 % -80.01 %
(Sep 30 2025)  


PROF's III. Quarter Q/Q Revenue Comment
Profound Medical Corp achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 296.37%, to $ 9.83 millions, from $2.48 millions in the second quarter.
PROF is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 183 other companies have achieved higher Revenue quarter on quarter growth. While Profound Medical 's Revenue growth quarter on quarter, overall rank is 3698.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #184
Healthcare Sector #538
Overall #3698
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #184
Healthcare Sector #538
Overall #3698
Revenue Q/Q Growth Statistics
High Average Low
139.21 % 8.46 % -80.01 %
(Sep 30 2025)  


PROF's III. Quarter Q/Q Revenue Comment
Profound Medical Corp achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 296.37%, to $ 9.83 millions, from $2.48 millions in the second quarter.
PROF is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 183 other companies have achieved higher Revenue quarter on quarter growth. While Profound Medical 's Revenue growth quarter on quarter, overall rank is 3698.


Profound Medical 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 23.63
Y / Y Revenue Growth (TTM) 65.26 %
Year on Year Revenue Growth Overall Ranking # 2157
Seqeuential Revenue Change (TTM) 23.79 %
Seq. Revenue Growth (TTM) Overall Ranking # 2653


Cumulative Revenue growth Comment
Profound Medical saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 65.26% year on year, to $ 24 millions if the fiscal year would have ended in Sep 30 2026.
Profound Medical 's trailing twelve months Revenue growth was higher than company's average 43.72% and higher than 61.2% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 23.79 % from $19.09 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at43.72%.

In the Healthcare sector 320 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 291 to 2157.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 321
Overall # 2157

Revenue TTM Y/Y Growth Statistics
High Average Low
61.2 %
 43.72 %
4.33 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 379
S&P 500 # 2653
Cumulative Revenue growth Comment
Profound Medical saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 65.26% year on year, to $ 24 millions if the fiscal year would have ended in Sep 30 2026.
Profound Medical 's trailing twelve months Revenue growth was higher than company's average 43.72% and higher than 61.2% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 23.79 % from $19.09 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at43.72%.
The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 23.79 % increase from $19.09 millions in the period from Jun 30 2026 to Sep 30 2025.

In the Healthcare sector 320 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 291 to 2157.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 321
Overall # 2157

Revenue TTM Y/Y Growth Statistics
High Average Low
61.2 %
43.72 %
4.33 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 379
S&P 500 # 2653




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PROF's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue doubling for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Neuraxis Inc 149.92%$ 149.922 millions
Pluri Inc 140.19%$ 140.190 millions
Camp4 Therapeutics Corporation138.87%$ 138.868 millions
Sonida Senior Living Inc 114.40%$ 114.402 millions
Verastem Inc 113.59%$ 113.592 millions
Hyperfine Inc 109.27%$ 109.270 millions
Pelthos Therapeutics Inc 107.87%$ 107.872 millions
Co diagnostics Inc 94.58%$ 94.580 millions
Autolus Therapeutics Plc94.57%$ 94.574 millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________93.02%$ 93.022 millions
Keros Therapeutics Inc 88.77%$ 88.766 millions
Profound Medical Corp 85.86%$ 85.857 millions
Vivosim Labs Inc 82.14%$ 82.143 millions
Syndax Pharmaceuticals Inc 81.59%$ 81.592 millions
Iovance Biotherapeutics inc 80.07%$ 80.074 millions
Rhythm Pharmaceuticals Inc 79.59%$ 79.594 millions
Omniab Inc 78.34%$ 78.339 millions
Aclarion Inc 78.09%$ 78.086 millions
Personalis Inc 76.59%$ 76.585 millions
Delcath Systems Inc 76.05%$ 76.047 millions
Mobia Medical Inc 73.28%$ 73.280 millions
Wave Life Sciences Ltd 72.95%$ 72.950 millions
Igc Pharma Inc 71.73%$ 71.728 millions
Phathom Pharmaceuticals Inc 71.14%$ 71.142 millions
Ptc Therapeutics inc 69.57%$ 69.571 millions
Seres Therapeutics Inc 68.95%$ 68.946 millions
Alamar Biosciences Inc 68.46%$ 68.458 millions
Carlsmed Inc 66.74%$ 66.736 millions
Corcept Therapeutics Inc63.97%$ 63.974 millions
Tarsus Pharmaceuticals Inc 63.92%$ 63.921 millions


About Profound Medical Revenue Growth Rates (PROF), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Profound Medical Corp (CIK 1628808).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001104659-26-123458
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Profound Medical Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.